phdassistance

  • Have any questions?

Call for Papers: Neurodegenerative Diseases: Basic, Clinical and Epidemiological Advances

Introduction

Publishing a research paper in this Special Issue provides an opportunity for researchers to present their works to an international scholarly audience and make important contributions to neurodegenerative disease research. The increasing number of elderly people who develop neurodegenerative disorders creates a global health crisis that imposes both financial and social burdens on society. The research aims to create an interdisciplinary framework that will study disease mechanisms while testing novel treatment methods. The Call for Papers on Neurodegenerative Diseases invites researchers to submit their original research studies, which will improve understanding across three scientific fields. The three scientific fields include molecular research, clinical research and epidemiological research.

Scientific research through neuroscience advancements shows how diseases develop through protein misfolding, neuroinflammation and genetic factors. They also enable better early diagnostic procedures and treatment research. The scientific advancements have created a situation where research results from laboratories fail to reach their intended use in medical settings. This Call for Papers Neuroscience Research submissions that bridge this gap by integrating basic science with clinical and translational research approaches.

The detection process, together with the treatment process for neurodegenerative diseases, shows changes that new technology brings through its development of advanced neuroimaging methods, fluid biomarker analysis and data-based analytical systems.

Submission deadline: 30 November 2026

Scope

  • The research study will examine multiple subjects while concentrating on its specific areas of study.
  • Researchers developed new diagnostic biomarkers through their work with CSF and blood-based testing methods.
  • Researchers study the diverse clinical symptoms that exist in neurodegenerative diseases to discover new treatment methods.
  • Clinical and Epidemiological Neurology Research studies how diseases develop and which factors increase their likelihood to occur.
  • The field of medicine develops new treatment methods through the use of gene therapy together with monoclonal antibody treatments.
  • The research studies clinical trials together with strategies that aim to create treatments that alter the progression of diseases.
  • The research papers on Alzheimer’s disease and Parkinson’s disease investigate both the disease mechanisms and available treatment options.
  • The research investigates Huntington’s disease and ALS together with Frontotemporal Dementia as research subjects.
  • The study investigates how neurogenetics, together with personalised medicine methods, develop new medical needs.

    • To publish your research papers in Scopus and PubMed-indexed journals, contact experts from the PhD Assistance research lab today!

    Know More About This Issue

    This special issue aims to provide a comprehensive perspective on the rapidly evolving field of neurodegenerative diseases through its research, which connects basic science with medical practice and disease study. Through the Call for Papers about Neurodegenerative Diseases, we invite researchers from different fields to conduct studies that connect molecular research with actual clinical settings in order to develop translational neuroscience.

    Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic Lateral Sclerosis and Frontotemporal Dementia create significant difficulties because these neurodegenerative diseases originate from multiple different causes. The issue requests research papers about Neurodegenerative Diseases, which should investigate important biological processes of protein aggregation and neuroinflammation and genetic factors that affect diagnosis and treatment.

    Clinicians can detect diseases earlier and track disease progression through new diagnostic technologies that utilise fluid biomarkers, which include CSF tests, blood tests and neuroimaging techniques. The Neurodegenerative Disorders Journal Submission supports research that implements these innovations into medical practice to enhance diagnostic precision and enable early treatment. The Clinical and Epidemiological Research studies show researchers how to identify disease patterns while they study risk factors.

    The issue also presents new treatment methods, which include gene therapies and monoclonal antibodies, and disease-modifying therapies. This special issue plans to create research that will produce significant scientific results by using knowledge from basic science, clinical research, and epidemiology to create research studies that will advance Alzheimer’s and Parkinson’s research and lead to better patient outcomes.

    Research Advances in Neurodegenerative Diseases

    Key Themes

  • The research development of Alzheimer’s and Parkinson’s studies
  • The use of biomarkers and early diagnostic tools
  • The study of neurogenetics and molecular neuroscience
  • The development of new therapies through clinical trials
  • The study of disease distribution and its impact on public health
  • The field of neuroimaging and digital health technology
  • Translational neuroscience research area of study

    • How We Support Your Submission

    At the PhD Assistance research lab, we offer expert manuscript writing and publication support for this special issue to PhD scholars and researchers.

    Our services include academic writing assistance, manuscript structuring, and technical editing to enhance clarity and quality. The authors receive our support to meet journal requirements while presenting their research results accurately.

    The additional support we offer to researchers includes plagiarism detection services, data presentation support, and assistance with handling reviewer comments. Our team provides support to you so you can meet the high academic standards required for your Neurodegenerative Diseases Research Paper, which will improve your chances of academic publication success.

    Journal Guidelines:

  • The journal accepts documents which fulfill the requirements of original and unpublished work.
  • Authors must ensure their research work matches all established research ethics requirements.
  • All submissions must follow the journal’s Guide for Authors.
  • The official submission system requires authors to submit their manuscripts.
  • The article type should be selected as “VSI: Neurodegenerative Diseases”.
  • The submitted work will undergo a review process by two independent experts in the domain.

    • The PhD assistance research lab offers structured manuscript writing and publication support to researchers.  To submit a high-quality research manuscript to the special issue “Neurodegenerative Diseases: Basic, Clinical and Epidemiological Advances”, contact our experts today.

    Free Guide: How to Write the Journal Manuscript

    Book a free consultation to get guidance from the PhD assistance research lab for writing a credible research manuscript and submitting it in the high-quality journal.

    Reference

    Revista de Investigación Clínica. (2026, April 2). Call for papers: Neurodegenerative diseases: Basic, clinical and epidemiological advances (Special issue). Elsevier. Revista de Investigación Clínica | ScienceDirect.com by Elsevier – Revista de Investigación Clínica | ScienceDirect.com by Elsevier

    Call For paper
    Generative AI on Educational Divide
    READ MORE
    Call For paper
    Manuscript Call on TinyML advancements in Intelligent Systems
    READ MORE
    Call For paper
    Abstract Submission Call on Big Data at IEEE international conference 2024
    READ MORE
    Call For paper
    IEEE Annual Congress on Artificial Intelligence of Things (AIoT)
    READ MORE
    We offer our Greatness in Various Parts of Research, and we help you with any phase of your Process. Make a Smart Decision and get your Paper Published.